Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Immunoglobulin 4-related disease (IgG4-RD) is known for its potential to affect nearly every organ, particularly a preference for large and middle-sized arteries when vascular involvement occurs.

A dentist has warned that a common symptom that many of us suffer with in our mouths could be a sign of cancer ...

Don’t Let Social Norms Hold You Back. Learn Online with TUKO. Enroll Now! Nairobi: Boniface Okinyi Oketch from Migori county is a man in pain after he developed a swelling in his abdomen. Migori man ...

Swelling inside your mouth is the most ... is cancerous and to differentiate it from other types of salivary gland cancer. The main treatments for polymorphous adenocarcinoma are surgery and ...

The thyroid gland is part of the endocrine system (along with the adrenal glands, hypothalamus, pituitary, ovaries, and testes, and other endocrine organs). The thyroid gland releases hormones into ...

A single treatment with, a CRISPR-Cas9 based gene ... painful and sudden onset of swelling, sometimes resulting in death. Confirming the findings published earlier this year from researchers ...